L-Arginine improves endothelial vasoreactivity and reduces thrombogenicity after thrombolysis in experimental deep venous thrombosis

Journal of Vascular Surgery

Volumn 38, Issue 6, 2003, Pages 1396-1403

  Lin, Peter H ^a,c   Johnson, Chris K ^b   Pullium, Jennifer K ^b   Bush, Ruth L ^b   Conklin, Brian S ^a   Chen, Changyi ^a   Lumsden, Alan B ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; ARGININE; NITRATE; NITRIC OXIDE; NITRITE; SODIUM CHLORIDE; TISSUE PLASMINOGEN ACTIVATOR;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOT LYSIS; CHEMOLUMINESCENCE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG MECHANISM; ENDOTHELIUM; FIBRIN DEPOSITION; FIBRINOLYTIC THERAPY; ILIAC VEIN; INTRAVASCULAR ULTRASOUND; NONHUMAN; POSTTHROMBOSIS SYNDROME; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SWINE; THROMBOCYTE AGGREGATION; THROMBOGENICITY; VASCULAR PATENCY;

EID: 0345599872     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0741-5214(03)00952-2     Document Type: Article

References (50)

1. Gupta R, Stouffer GA. Deep venous thrombosis: a review of the pathophysiology, clinical features, and diagnostic modalities. Am J Med Sci 2001;322:358-64.
2. Reinisch JF, Bresnick SD, Walker JW, Rosso RF. Deep venous thrombosis and pulmonary embolus after face lift: a study of incidence and prophylaxis. Plast Reconstr Surg 2001;107:1570-5; discussion 1576-7.
3. Cambria RA, Lowell RC, Gloviczki P, Miller VM. Chronic changes in blood flow alter endothelium-dependent responses in autogenous vein grafts in dogs. J Vasc Surg 1994;20:765-73.
4. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-6.
5. Pawlak R, Chabielska E, Golatowski J, Azzadin A, Buczko W. Nitric oxide and prostacyclin are involved in antithrombotic action of captopril in venous thrombosis in rats. Thromb Haemost 1998;79:1208-12.
6. Cho JS, Martelli E, Mozes G, Miller VM, Gloviczki P. Effects of thrombolysis and venous thrombectomy on valvular competence, thrombogenicity, venous wall morphology, and function. J Vasc Surg 1998;28:787-99.
7. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-12.
8. Broeders MA, Tangelder GJ, Slaaf DW, Reneman RS, Egbrink MG. Endogenous nitric oxide protects against thromboembolism in venules but not in arterioles. Arterioscler Thromb Vasc Biol 1998;18:139-45.
9. Broeders MA, Tangelder GJ, Slaaf DW, Reneman RS, Egbrink MG. Endogenous nitric oxide and prostaglandins synergistically counteract thromboembolism in arterioles but not in venules. Arterioscler Thromb Vasc Biol 2001;21:163-9.
10. Lin PH, Chen C, Surowiec SM, Conklin B, Bush RL, Lumsden AB. Evaluation of thrombolysis in a porcine model of chronic deep venous thrombosis: an endovascular model. J Vasc Surg 2001;33:621-7.
11. Lin PH, Surowiec SM, Conklin B, Chen C, Bush R, et al. Evaluation of thrombolysis and angioplasty in a porcine iliac artery thrombosis model: application of endovascular stent-graft-induced thrombosis. J Vasc Interv Radiol 2000;11:785-91.
12. Lin PH, Surowiec SM, Conklin B, Bush RL, Chen C, et al. An endovascular model of carotid stenosis for the evaluation of thrombolysis and angioplasty. J Endovasc Ther 2000;7:486-93.
13. Lin PH, Chen C, Surowiec SM, Conklin B, Bush RL, et al. A porcine model of carotid artery thrombosis for thrombolytic therapy and angioplasty: application of PTFE graft-induced stenosis. J Endovasc Ther 2000;7:227-35.
14. Yao SK, Akhtar S, Scott-Burden T, Ober JC, Golino P, et al. Endogenous and exogenous nitric oxide protect against intracoronary thrombosis and reocclusion after thrombolysis. Circulation 1995;92:1005-10.
15. Yao SK, Ober JC, Krishnaswami A, Ferguson JJ, Anderson HV, et al. Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries. Circulation 1992;86:1302-9.
16. Surowiec SM, Conklin BS, Li JS, Lin PH, Weiss VJ, et al. A new perfusion culture system used to study human vein. J Surg Res 2000;88:34-41.
17. Conklin BS, Surowiec SM, Ren Z, Li JS, Zhong DS, et al. Effects of nicotine and cotinine on porcine arterial endothelial cell function. J Surg Res 2001;95:23-31.
18. Chen C, Conklin BS, Ren Z, Zhong DS. Homocysteine decreases endothelium-dependent vasorelaxation in porcine arteries. J Surg Res 2002;102:22-30.
19. Rhodes JM, Cho JS, Gloviczki P, Mozes G, Rolle R, Miller VM. Thrombolysis for experimental deep venous thrombosis maintains valvular competence and vasoreactivity. J Vasc Surg 2000;31:1193-1205.
20. Chen C, Mattar SG, Lumsden AB. Oral administration of L-arginine reduces intimal hyperplasia in balloon-injured rat carotid arteries. J Surg Res 1999;82:17-23.
21. Chen C, Lumsden AB, Hanson SR. Local infusion of heparin reduces anastomotic neointimal hyperplasia in aortoiliac expanded polytetrafluoroethylene bypass grafts in baboons. J Vasc Surg 2000;31:354-63.
22. Comerota AJ, Aldridge SC, Cohen G, Ball DS, Pliskin M, White JV. A strategy of aggressive regional therapy for acute iliofemoral venous thrombosis with contemporary venous thrombectomy or catheter-directed thrombolysis. J Vasc Surg 1994;20:244-54.
23. Meissner MH, Manzo RA, Bergelin RO, Markel A, Strandness DE Jr. Deep venous insufficiency: the relationship between lysis and subsequent reflux. J Vasc Surg 1993;18:596-605; discussion 606-8.
24. Meissner MH, Caps MT, Zierler BK, Bergelin RO, Manzo RA, Strandness DE Jr. Deep venous thrombosis and superficial venous reflux. J Vasc Surg 2000;32:48-56.
25. Radomski MW, Vallance P, Whitley G, Foxwell N, Moncada S. Platelet adhesion to human vascular endothelium is modulated by constitutive and cytokine induced nitric oxide. Cardiovasc Res 1993;27:1380-2.
26. Miller VM, Barber DA. Modulation of endothelium-derived nitric oxide in canine femoral veins. Am J Physiol 1996;271:H668-73.
27. Kelm M, Schrader J. Control of coronary vascular tone by nitric oxide. Circ Res 1990;66:1561-75.
28. Panza JA, Casino PR, Badar DM, Quyyumi AA. Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension. Circulation 1993;87:1475-81.
29. Willerson JT, Igo SR, Yao SK, Ober JC, Macris MP, Ferguson JJ. Localized administration of sodium nitroprusside enhances its protection against platelet aggregation in stenosed and injured coronary arteries. Tex Heart Inst J 1996;23:1-8.
30. Hackett D, Davies G, Chierchia S, Maseri A. Intermittent coronary occlusion in acute myocardial infarction: value of combined thrombolytic and vasodilator therapy. N Engl J Med 1987;317:1055-9.
31. 1, and nitroglycerin. Circ Res 1989;65:796-804.
32. Kashyap VS, Reil TD, Moore WS, Hoang TX, Gelabert HA, et al. Acute arterial thrombosis causes endothelial dysfunction: a new paradigm for thrombolytic therapy. J Vasc Surg 2001;34:323-9.
33. Manicone JA, Eisenbud DE, Hertz SM, Brener BJ, Creighton D, et al. The effect of thrombus on the vascular endothelium of arterialized vein grafts. Am J Surg 1996;172:163-6; discussion 167.
34. Whitley D, Gloviczki P, Rhee R, Tazelaar HD, Miller V. Urokinase treatment preserves endothelial and smooth muscle function in experimental acute arterial thrombosis. J Vasc Surg 1996;23:851-8; discussion 858-9.
35. Wengrovitz M, Healy DA, Gifford RR, Atnip RG, Thiele BL. Thrombolytic therapy and balloon catheter thrombectomy in experimental femoral artery thrombosis: effect on arterial wall morphology. J Vasc Interv Radiol 1995;6:205-10.
36. Tanaka H, Sukhova GK, Swanson SJ, Clinton SK, Ganz P, et al. Sustained activation of vascular cells and leukocytes in the rabbit aorta after balloon injury. Circulation 1993;88:1788-1803.
37. Downing LJ, Strieter RM, Kadell AM, Wilke CA, Brown SL, et al. Neutrophils are the initial cell type identified in deep venous thrombosis induced vein wall inflammation. ASAIO J 1996;42:M677-82.
38. Toursarkissian B, Schwartz D, Eisenberg PR, Rubin BG. Arterial thrombosis induces early upregulation of intercellular adhesion molecule in the media. J Vasc Surg 1997;26:663-9.
39. Wakefield TW, Strieter RM, Wilke CA, Kadell AM, Wrobleski SK, et al. Venous thrombosis-associated inflammation and attenuation with neutralizing antibodies to cytokines and adhesion molecules. Arterioscler Thromb Vasc Biol 1995;15:258-68.
40. Wakefield TW, Strieter RM, Downing LJ, Kadell AM, Wilke CA, et al. P-selectin and TNF inhibition reduce venous thrombosis inflammation. J Surg Res 1996;64:26-31.
41. Downing LJ, Wakefield TW, Strieter RM, Prince MR, Londy FJ, et al. Anti-P-selectin antibody decreases inflammation and thrombus formation in venous thrombosis. J Vasc Surg 1997;25:816-27; discussion 828.
42. Persson MG, Gustafsson LE, Wiklund NP, Hedqvist P, Moncada S. Endogenous nitric oxide as a modulator of rabbit skeletal muscle microcirculation in vivo. Br J Pharmacol 1990;100:463-6.
43. Kurose I, Kubes P, Wolf R, Anderson DC, Paulson J, et al. Inhibition of nitric oxide production: mechanisms of vascular albumin leakage. Circ Res 1993;73:164-71.
44. Wang BY, Singer AH, Tsao PS, Drexler H, Kosek J, Cooke JP. Dietary arginine prevents atherogenesis in the coronary artery of the hypercholesterolemic rabbit. J Am Coll Cardiol 1994;23:452-8.
45. Jiang J, Valen G, Tokuno S, Thoren P, Pernow J. Endothelial dysfunction in atherosclerotic mice: improved relaxation by combined supplementation with L-arginine-tetrahydrobiopterin and enhanced vasoconstriction by endothelin. Br J Pharmacol 2000;131:1255-61.
46. Boger RH, Bode-Boger SM, Kienke S, Stan AC, Nafe R, Frolich JC. Dietary L-arginine decreases myointimal cell proliferation and vascular monocyte accumulation in cholesterol-fed rabbits. Atherosclerosis 1998;136:67-77.
47. Davies MG, Fulton GJ, Huynh TT, Barber L, Svendsen E, Hagen PO. Combination therapy of cholesterol reduction and L-arginine supplementation controls accelerated vein graft atheroma. Ann Vasc Surg 1999;13:484-93.
48. Tarry WC, Makhoul PG. L-Arginine improves endothelium-dependent vasorelaxation and reduces intimal hyperplasia after balloon angioplasty. Arterioscler Thromb 1994;14:938-43.
49. Schwarzacher SP, Lim TT, Wang B, Kernoff RS, Niebauer J, et al. Local intramural delivery of L-arginine enhances nitric oxide generation and inhibits lesion formation after balloon angioplasty. Circulation 1997;95:1863-9.
50. Landis ME, Ray EC, Gloviczki P, Miller VM. Effects of dietary L-arginine on structure and function of flow-restricted vein grafts. J Vasc Surg 2001;33:829-39.